Understanding Intra-Aortic Balloon Pump Technology. The IABP was first used in humans in the 1960s. It was the first type of ...

The IABP, developed in the 1960s, was the first device to provide temporary mechanical support to the heart in patients with cardiogenic shock, Sacco said.

The balloon pump can help improve the heart’s ability to pump blood as it needs to. Through a surgical procedure, the device is inserted through your leg into the heart.

Early IABP use no better than medication in cardiogenic shock due to heart failure Altshock-2 trial stopped early when device deemed not superior to standard medical care ...

To date, 4,454 of Getinge’s IABP devices have been recalled in the U.S. 98% clean claims, faster payments: How ModMed practices are improving RCM Recommended Live Webinar on Jun 26, 2025 11:00 ...

Interv Cardiol. 2012;4(2):211-234. The future of IABC cannot, however, be taken in isolation. It must be analyzed in the context of other PCADs available for in-human use, namely the Impella ...

Compared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in patients who were critically ill with cardiogenic shock caused by heart ...

The FDA said that some of the reports describe Cardiosave IABP devices shutting down, it has also been evaluating other concerns with the IABP, including blood entering the device, ...

There is a shortage of Getinge Maquet/Datascope Intra-Aortic Balloon Pump devices, and the supply issue will continue into 2023, according to the FDA.The agency said it is working with Getinge to ...

Interpretation. Among patients with cardiogenic shock due to AMI, the Impella device resulted in a greater change in 30-minute cardiac index compared with the IABP; however, at all measured time ...

The U.S Food and Drug Administration (FDA) on Wednesday advised healthcare facilities to move away from using Getinge's heart devices in patients as they faced safety and quality concerns despite ...